A(2A) adenosine receptor: a novel therapeutic target in renal disease.
about
A2A receptors in inflammation and injury: lessons learned from transgenic animalsRole of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertensionOlprinone attenuates the acute inflammatory response and apoptosis after spinal cord trauma in miceIdentification of zebrafish A2 adenosine receptors and expression in developing embryosCytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis.Role of 2',3'-cyclic nucleotide 3'-phosphodiesterase in the renal 2',3'-cAMP-adenosine pathwayAcute kidney injury: a springboard for progression in chronic kidney diseaseAdenosine receptors and caffeine in retinopathy of prematurity.Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.Guanosine regulates adenosine levels in the kidneyThe guanosine-adenosine interaction exists in vivo.Adenosine receptors and renal ischaemia reperfusion injury.Protective role of AMP-activated protein kinase-evoked autophagy on an in vitro model of ischemia/reperfusion-induced renal tubular cell injury.The 2',3'-cAMP-adenosine pathwayGenetic inactivation of the adenosine A2A receptor attenuates pathologic but not developmental angiogenesis in the mouse retinaAdenosine and protection from acute kidney injury.Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo.A1 adenosine receptor allosteric enhancer PD-81723 protects against renal ischemia-reperfusion injuryExtracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cellsAdenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?Sesamin protects against renal ischemia reperfusion injury by promoting CD39-adenosine-A2AR signal pathway in mice.In vivo cardiovascular pharmacology of 2',3'-cAMP, 2'-AMP, and 3'-AMP in the ratHigh-salt diet enhances mouse aortic relaxation through adenosine A2A receptor via CYP epoxygenases.Ectonucleotidases in the kidney.Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive.Dietary K intake regulates the response of apical K channels to adenosine in the thick ascending limb.Regulatory T cells in Acute and Chronic Kidney Diseases.
P2860
Q24652486-CF9F91B3-2C7F-45F2-95A9-C00034E2F5E7Q27000348-C517DF46-74CA-4634-96D2-C4801A4A3144Q28475420-2FB0A800-733E-4364-B758-1CD4ECA7A242Q30436906-8A2E8173-06C3-450B-8239-8BF5DA472B1BQ30881980-2483FD66-5364-409B-9DB5-742344F5F17CQ33839974-4A0F7FEB-4EF1-406E-9E14-E63F9DADF690Q33840576-01773DF5-DB15-4554-9D9C-42F6A8C5D993Q33860622-A35F66BD-2E42-4DED-B901-040570F62EB3Q33882297-7E21F33B-4120-4FFE-BF9D-6B1B1C802C08Q33902942-3BE840BE-E590-4FAD-824F-33D84E847EC5Q34125107-D47E58E9-6A86-488A-B060-2C840230EE5EQ34735024-B9803EF0-D940-401F-A95F-9FCC0A162E67Q35040337-AAD74DD6-521C-4EA5-8D1A-13A595808029Q35601599-0675E486-68F1-4A01-92F5-E14F586278CEQ35680153-80036A9E-6569-4581-B7C5-B93F6A28529DQ35755490-2E5BEC36-0DE3-4F38-A969-DCD5F4A1BA8FQ35847438-91FFA85A-C9CB-4653-9D8B-4C804316D9E7Q36309390-A4F9D88A-E498-4D01-B511-BB15D591E89BQ36527859-BCB44FAD-82EB-4BD4-91D0-ED1FC7C6E6A1Q36821572-D72DFF06-2DC5-4497-A5BC-1B5D9DDB48D1Q36964153-34212B6E-EB1A-41D0-80A6-F574CA96708FQ37027031-7CE7C1AA-F4CB-4C21-AC61-740F917EDF2FQ37151075-B71A2B6C-2782-4BA0-9B7F-0D98EB96DDBCQ37427521-7FF74519-5754-43AE-B3D8-A455688704BDQ37462422-F326922B-6053-476E-99A2-68993CFB6891Q44987311-D412925B-78DF-4F87-866A-B99B0514D0A8Q45066685-BBB38CD0-DF89-430B-9325-0BA09735C510
P2860
A(2A) adenosine receptor: a novel therapeutic target in renal disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A(2A) adenosine receptor: a novel therapeutic target in renal disease.
@ast
A(2A) adenosine receptor: a novel therapeutic target in renal disease.
@en
type
label
A(2A) adenosine receptor: a novel therapeutic target in renal disease.
@ast
A(2A) adenosine receptor: a novel therapeutic target in renal disease.
@en
prefLabel
A(2A) adenosine receptor: a novel therapeutic target in renal disease.
@ast
A(2A) adenosine receptor: a novel therapeutic target in renal disease.
@en
P1476
A(2A) adenosine receptor: a novel therapeutic target in renal disease.
@en
P356
10.1152/AJPRENAL.2002.282.1.F10
P577
2002-01-01T00:00:00Z